247 results
Page 8 of 13
8-K
EX-99.2
7jecrsy
6 Dec 21
Aeglea BioTherapeutics Announces Achievement of Primary Endpoint in Phase 3 Study of Pegzilarginase in Patients with Arginase 1 Deficiency
6:30am
8-K
EX-99.1
z5adiu95 on1z2gxhlaj
4 Nov 21
Aeglea BioTherapeutics Reports Third Quarter 2021 Financial Results and Corporate Highlights
7:01am
8-K
x3cfuswqg
9 Sep 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
amy4qb6p
9 Sep 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
yaorumatg5ezglpp7
5 Aug 21
Aeglea BioTherapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights
8:30am
8-K
y49mqf v6j
24 Jun 21
Other Events
8:31am
8-K
EX-99.1
sl9k 06nv56ss9sr47
10 May 21
Aeglea BioTherapeutics Reports First Quarter 2021 Financial Results and Corporate Highlights
8:30am
8-K
gfsa eo1o
22 Mar 21
Entry into a Material Definitive Agreement
8:30am
8-K
EX-99.2
7dicvv63qa6q4 5umzqk
18 Mar 21
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
8:31am
8-K
EX-99.1
6q2re7
18 Mar 21
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
8:31am
8-K
EX-99.1
8yg89whkjtde
5 Jan 21
Regulation FD Disclosure
8:30am
8-K
itsnp1 yha
5 Jan 21
Regulation FD Disclosure
8:30am